INVA Competitors & Alternatives
Compare Innoviva Inc with similar stocks in the same industry
Biotechnology
INVA
Main Stock$21.07
Tradestie Score
45
Market Cap
$1.15B
P/E Ratio
5.0
Revenue Growth
0.2%
Analyst Upside
+66.1%
Top Competitors
240 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
BHVN
Biohaven Ltd.
|
$13.85
|
$1.57B | - | 49 | Compare |
|
VCEL
Vericel Corporation
|
$42.68
|
$1.56B | 87.7 | 53 | Compare |
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$111.10
|
$1.55B | - | 42 | Compare |
|
HRMY
Harmony Biosciences Holdings, Inc. Common Stock
|
$38.15
|
$1.55B | 12.9 | 49 | Compare |
|
PHVS
Pharvaris N.V. Ordinary Shares
|
$36.27
|
$1.55B | - | 44 | Compare |
|
NVAX
Novavax Inc
|
$8.94
|
$1.54B | - | 38 | Compare |
|
AUPH
Aurinia Pharmaceuticals Inc
|
$16.65
|
$1.50B | 7.6 | 40 | Compare |
|
GPCR
Structure Therapeutics Inc. American Depositary Shares
|
$49.09
|
$1.50B | - | 38 | Compare |
|
AMLX
Amylyx Pharmaceuticals, Inc. Common Stock
|
$38.66
|
$1.49B | - | 41 | Compare |
|
RCUS
Arcus Biosciences, Inc.
|
$30.34
|
$1.43B | - | 40 | Compare |
More INVA Analysis
Data updated: Aug 24, 2026 | Industry: Biotechnology (SIC 2834)
240 stocks in this industry